Skip to content

This website is intended for UK healthcare professionals only

This is a promotional website developed by AstraZeneca

The prescribing information can be found at the bottom of the page



Intended audience is for UK HCPs

Tagrisso® (Osimertinib) Connect –
New Content Coming Soon

Adverse events should be reported. Reporting forms and information can be found at or
search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting or by calling 0800 783 0033.